Sign in
TerminatedNo phase

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Key facts

Who runs it
M.D. Anderson Cancer Center
Where
Houston, United StatesSee the 2 sites
Trial code
Status
Terminated
People taking part
409 people enrolled
Started
27 Oct 2014
Ended
8 Jul 2025
Type of study
Interventional
Treatments tested
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
Record updated
14 July 2025

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Women with histologically confirmed cervical, vaginal or vulvar high-grade dysplasia, invasive squamous cell carcinoma, invasive adenocarcinoma, or adenocarcinoma-in-situ (AIS). All stages and grades will be eligible
  • Women with a diagnosis of high grade intraepithelial lesion (HSIL) from a routine pap test
  • Patients must sign an approved informed consent document

Who cannot take part

  • Patients with previously documented perianal squamous cell dysplasia or invasive squamous cell carcinoma of the anus or anal canal
  • Patients with previously documented HPV related oropharyngeal cancer
  • Patients unwilling or unable to provide informed consent for the study
  • Male patients will not be included in this study

Where in United States

  • Lyndon Baines Johnson General HospitalHouston, United States
  • M D Anderson Cancer CenterHouston, United States

About the trial

What the trial wants to find out

This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collected from patients in the laboratory may help doctors learn more about the human papillomavirus and how often anal cancer occurs in patients with cervix, vagina, or vulvar cancer.

The group in the trial

  • Screening (biospecimen collection)Treatment being tested

    Patients undergo collection of anal, cervical, vaginal, and oral samples during their scheduled pelvic exam.

    Treatment: Biospecimen Collection and Laboratory Biomarker Analysis

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Record updated
14 July 2025